Page 8 of 10 – SEC Filing
| C. | Brosh GP |
| | (a) | As the general partner of Brosh, Brosh GP may be deemed the beneficial owner of the 1,296,564 Shares beneficially owned by Brosh. |
Percentage: Approximately 4.7%
| | (b) | 1. Sole power to vote or direct vote: 0 |
| | 2. Shared power to vote or direct vote: 1,296,564 |
| | 3. Sole power to dispose or direct the disposition: 0 |
| | 4. Shared power to dispose or direct the disposition: 1,296,564 |
| | (c) | Brosh GP has not entered into any transactions in the Shares since the filing of Amendment No. 2 to the Schedule 13D. The transactions in the Shares by Brosh since the filing of Amendment No. 2 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference. |
| D. | Exodus GP |
| | (a) | As the general partner of Exodus, Exodus GP may be deemed the beneficial owner of the (i) 1,562,397 Shares beneficially owned by Exodus and (ii) 144,108 Shares held in the Exodus Managed Account. |
Percentage: Approximately 6.2%
| | (b) | 1. Sole power to vote or direct vote: 0 |
| | 2. Shared power to vote or direct vote: 1,706,505 |
| | 3. Sole power to dispose or direct the disposition: 0 |
| | 4. Shared power to dispose or direct the disposition: 1,706,505 |
| | (c) | Exodus GP has not entered into any transactions in the Shares since the filing of Amendment No. 2 to the Schedule 13D. The transactions in the Shares by Exodus and on behalf of the Exodus Managed Account since the filing of Amendment No. 2 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference. |
| E. | Mr. Efrati |
| | (a) | Mr. Efrati as the portfolio manager of each of Brosh and Exodus, may be deemed the beneficial owner of the (i) 1,296,564 Shares owned by Brosh; (ii) 1,562,397 Shares owned by Exodus and (iii) 144,108 Shares held in the Exodus Managed Account. |
Percentage: Approximately 10.9%
| | (b) | 1. Sole power to vote or direct vote: 0 |
| | 2. Shared power to vote or direct vote: 3,003,069 |
| | 3. Sole power to dispose or direct the disposition: 0 |
| | 4. Shared power to dispose or direct the disposition: 3,003,069 |
| | (c) | Mr. Efrati has not entered into any transactions in the Shares since the filing of Amendment No. 2 to the Schedule 13D. The transactions in the Shares by Exodus and on behalf of the Exodus Managed Account since the filing of Amendment No. 2 to the Schedule 13D are set forth in Schedule A and are incorporated herein by reference. |
The filing of this Schedule 13D shall not be construed as an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any of the securities reported herein. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that are not directly owned by such Reporting Person, except to the extent of their pecuniary interest therein.
Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)
Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
